Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Neurogastroenterol Motil. 2021 Apr 2;33(12):e14145. doi: 10.1111/nmo.14145

TABLE 3.

Study cohort’s IBS characteristics (N=461).

Variable n (%) or mean ± standard deviation
IBS subtype:
   IBS-C 113 (24.5)
   IBS-D 126 (27.3)
   IBS-M 221 (47.9)
   IBS-U 1 (0.2)
Most bothersome IBS symptom:
   Abdominal pain 258 (56.0)
   Constipation 100 (21.7)
   Diarrhea 92 (20.0)
   Not sure 11 (2.4)
Number of acute pain episodes in past month:
   2 episodes 89 (19.3)
   3 episodes 129 (28.0)
   ≥4 episodes 243 (52.7)
Average severity of acute pain episodes in past month (0-10 scale):
   4 21 (4.6)
   5 42 (9.1)
   6 86 (18.7)
   7 138 (29.9)
   8 111 (24.1)
   9 28 (6.1)
   10 35 (7.6)
PROMIS abdominal pain score (percentile) 78.5 ± 17.0
Currently taking IBS medicine 343 (74.4)
Currently taking other medicine for pain 433 (93.9)

IBS, irritable bowel syndrome; IBS-C, irritable bowel syndrome with constipation; IBS-D, irritable bowel syndrome with diarrhea; IBS-M, mixed irritable bowel syndrome; IBS-U, unsubtyped irritable bowel syndrome; PROMIS, Patient-Reported Outcomes Measurement Information System.

Assesses severity of respondents’ abdominal pain in the past week. Higher score corresponds to more severe symptoms.